Ranny Yaffe
Vorstandsvorsitzender bei VESSL Therapeutics Ltd.
Profil
Ranny Yaffe is currently the Co-Chief Executive Officer at VESSL Therapeutics Ltd.
He started this position in 2020.
Prior to his current role, Mr. Yaffe obtained an undergraduate degree and an MBA from Technion-Israel Institute of Technology.
Aktive Positionen von Ranny Yaffe
| Unternehmen | Position | Beginn |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Vorstandsvorsitzender | 01.01.2020 |
Ausbildung von Ranny Yaffe
| Technion-Israel Institute of Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
